ROTARIX human rotavirus (live attenuated oral vaccine) oral liquid

GlaxoSmithKline Australia Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: edfd3168e2479dd3
Product Name: ROTARIX human rotavirus (live attenuated oral vaccine) oral liquid
Artg Id: 146776
Artg Name: ROTARIX human rotavirus (live attenuated oral vaccine) oral liquid
Sponsor: GlaxoSmithKline Australia Pty Ltd
Company Detail Path: /organization/glaxosmithkline-australia-pty-ltd
Artg Date: 2008-08-27
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Consumer Medicine Info: http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2022-CMI-02220-1
Product Information: http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2010-PI-06401-3

Approved

Agency

TGA

Country

🇦🇺

Approval Date

Dec 9, 2025

Approval ID

edfd3168e2479dd3

Type

Standard